Mechanisms of Disease: the pathogenesis of pituitary tumors
Authors:
- 1 April 2006
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Endocrinology & Metabolism
- Vol. 2 (4) , 220-230
Abstract
Pituitary tumors exhibit a spectrum of biology, with variable growth and hormonal behaviors. They therefore provide an opportunity to examine pathogenetic mechanisms that underlie the neoplastic process. These include alterations in hormone regulation, growth-factor stimulation, cell-cycle control and cell-stromal interactions that result from genetic mutations or epigenetic disruption of gene expression. Mouse models have validated the roles of these alterations, which can be targets for the development of therapies that can manage these lesions. These therapies are increasingly recognized as critical for quality of life.Keywords
This publication has 61 references indexed in Scilit:
- The prevalence of pituitary adenomasCancer, 2004
- Pituitary tumors and pregnancyGrowth Hormone & IGF Research, 2003
- The pathogenesis of pituitary tumoursNature Reviews Cancer, 2002
- Adenovirus-directed Expression of Dominant Negative Estrogen Receptor Induces Apoptosis in Breast Cancer Cells and Regression of Tumors in Nude MiceMolecular Medicine, 2001
- Two-year treatment with oral contraceptives in hyperprolactinemic patientsContraception, 1998
- Pituitary Lactotroph Hyperplasia and Chronic Hyperprolactinemia in Dopamine D2 Receptor-Deficient MiceNeuron, 1997
- The Role of Hypothalamic Hormones in the Pathogenesis of Pituitary AdenomasPathology - Research and Practice, 1991
- Comparison of the Sensitivity of Growth Hormone Secretion to Somatostatinin Vivoandin Vitroin Acromegaly*The Journal of Clinical Endocrinology & Metabolism, 1988
- Morphological Evidence for the Presence of Arteries in Human Prolactinomas*The Journal of Clinical Endocrinology & Metabolism, 1988
- Ectopic Secretion of Corticotropin-Releasing Factor as a Cause of Cushing’s SyndromeNew England Journal of Medicine, 1984